Annual Shareholders Equity
-$131.19 M
-$22.00 M-20.15%
31 December 2023
Summary:
Galera Therapeutics annual stockholders equity is currently -$131.19 million, with the most recent change of -$22.00 million (-20.15%) on 31 December 2023. During the last 3 years, it has fallen by -$137.30 million (-2244.25%). GRTX annual shareholders equity is now -288.46% below its all-time high of $69.61 million, reached on 31 December 2019.GRTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$138.03 M
-$3.34 M-2.48%
30 June 2024
Summary:
Galera Therapeutics quarterly stockholders equity is currently -$138.03 million, with the most recent change of -$3.34 million (-2.48%) on 30 June 2024. Over the past year, it has dropped by -$11.48 million (-9.07%). GRTX quarterly shareholders equity is now -298.30% below its all-time high of $69.61 million, reached on 31 December 2019.GRTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | -9.1% |
| 3 y3 years | -2244.3% | -219.8% |
| 5 y5 years | -25.1% | +4.6% |
GRTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2244.3% | at low | -219.8% | at low |
| 5 y | 5 years | -288.5% | at low | -298.3% | +4.6% |
| alltime | all time | -288.5% | at low | -298.3% | +4.6% |
Galera Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$138.03 M(+2.5%) |
| Mar 2024 | - | -$134.69 M(+2.7%) |
| Dec 2023 | -$131.19 M(+20.2%) | -$131.19 M(+3.7%) |
| Sept 2023 | - | -$126.55 M(+10.0%) |
| June 2023 | - | -$115.00 M(+17.8%) |
| Mar 2023 | - | -$97.61 M(-10.6%) |
| Dec 2022 | -$109.18 M(+88.2%) | -$109.18 M(+12.0%) |
| Sept 2022 | - | -$97.50 M(+17.1%) |
| June 2022 | - | -$83.25 M(+18.1%) |
| Mar 2022 | - | -$70.47 M(+21.5%) |
| Dec 2021 | -$58.00 M | -$58.00 M(+34.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$43.17 M(+69.2%) |
| June 2021 | - | -$25.52 M(+141.3%) |
| Mar 2021 | - | -$10.57 M(-272.8%) |
| Dec 2020 | $6.12 M(-91.2%) | $6.12 M(-75.2%) |
| Sept 2020 | - | $24.70 M(-38.6%) |
| June 2020 | - | $40.24 M(-24.2%) |
| Mar 2020 | - | $53.06 M(-23.8%) |
| Dec 2019 | $69.61 M(-166.4%) | $69.61 M(-148.1%) |
| Sept 2019 | - | -$144.62 M(-458.7%) |
| June 2019 | - | $40.32 M(-138.5%) |
| Dec 2018 | -$104.82 M(+37.7%) | -$104.82 M |
| Dec 2017 | -$76.11 M | - |
FAQ
- What is Galera Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Galera Therapeutics?
- What is Galera Therapeutics annual shareholders equity year-on-year change?
- What is Galera Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Galera Therapeutics?
- What is Galera Therapeutics quarterly shareholders equity year-on-year change?
What is Galera Therapeutics annual stockholders equity?
The current annual shareholders equity of GRTX is -$131.19 M
What is the all time high annual shareholders equity for Galera Therapeutics?
Galera Therapeutics all-time high annual stockholders equity is $69.61 M
What is Galera Therapeutics annual shareholders equity year-on-year change?
Over the past year, GRTX annual stockholders equity has changed by -$22.00 M (-20.15%)
What is Galera Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of GRTX is -$138.03 M
What is the all time high quarterly shareholders equity for Galera Therapeutics?
Galera Therapeutics all-time high quarterly stockholders equity is $69.61 M
What is Galera Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, GRTX quarterly stockholders equity has changed by -$11.48 M (-9.07%)